Structure Therapeutics Income Statement (2022-2026) | GPCR

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 8.49M10.18M9.16M8.36M13.13M19.41M17.52M20.04M20.68M22.05M32.60M33.49M42.87M54.71M58.99M68.69M66.51M
Selling, General & Administrative (Quarter) 4.46M3.78M3.53M4.60M6.51M6.58M8.63M10.95M11.34M11.27M13.24M13.57M13.44M15.74M14.80M17.57M22.87M
Other Operating Expenses (Quarter) -110.25M
Operating Expenses (Quarter) 12.95M13.96M12.69M12.96M19.65M25.99M26.14M30.99M32.02M33.32M45.84M47.06M56.31M70.45M73.79M-23.99M89.38M
Operating Income (Quarter) -12.95M-13.96M-12.69M-12.96M-19.65M-25.99M-26.14M-30.99M-32.02M-33.32M-45.84M85.50M-56.31M-70.45M-73.79M171.00M-89.38M
EBIT (Quarter) -12.95M-13.96M-12.69M-12.96M-19.65M-25.99M-26.14M-30.99M-32.02M-33.32M-45.84M85.50M-56.31M-70.45M-73.79M171.00M-89.38M
Non-operating items
Interest & Investment Income (Quarter) -0.07M0.08M0.35M0.90M1.70M2.83M2.69M6.18M6.01M7.33M11.95M10.72M9.58M8.93M8.18M9.19M13.60M
Net income details
EBT (Quarter) -13.02M-13.88M-12.34M-5.01M-17.95M-23.16M-23.46M55.08M-26.01M-25.98M-33.88M-27.23M-46.73M-61.52M-65.60M177.25M-75.78M
Tax Provisions (Quarter) 0.06M0.06M0.07M-0.18M0.03M0.12M0.41M-0.33M0.03M0.05M0.09M0.14M0.10M0.14M0.11M0.17M0.19M
Profit After Tax (Quarter) -13.08M-13.95M-12.42M-11.88M-17.98M-23.28M-23.86M-24.50M-26.04M-26.03M-33.98M-36.48M-46.83M-61.66M-65.71M33.00M-75.97M
Income from Continuing Operations (Quarter) -13.08M-13.95M-12.42M-4.83M-17.98M-23.28M-23.86M55.41M-26.04M-26.03M-33.98M-27.37M-46.83M-61.66M-65.71M177.08M-75.97M
Consolidated Net Income (Quarter) -13.08M-13.95M-12.42M-4.83M-17.98M-23.28M-23.86M55.41M-26.04M-26.03M-33.98M-27.37M-46.83M-61.66M-65.71M177.08M-75.97M
Income towards Parent Company (Quarter) -13.08M-13.95M-12.42M-4.83M-17.98M-23.28M-23.86M55.41M-26.04M-26.03M-33.98M-27.37M-46.83M-61.66M-65.71M177.08M-75.97M
Net Income towards Common Stockholders (Quarter) -13.08M-13.95M-12.42M-4.83M-17.98M-23.28M-23.86M55.41M-26.04M-26.03M-33.98M-27.37M-46.83M-61.66M-65.71M177.08M-75.97M
Additional items
EPS (Basic) (Quarter) -1.44-1.64-1.27-1.17-0.25-0.20-0.21-0.16-0.19-0.18-0.20-0.22-0.27-0.36-0.370.20-0.35
EPS (Weighted Average and Diluted) (Quarter) -1.44-1.64-1.27-1.17-0.25-0.20-0.21-0.16-0.19-0.18-0.20-0.22-0.27-0.36-0.370.20-0.35
Shares Outstanding (Weighted Average) (Quarter) 9.06M9.25M9.43M9.58M71.66M93.33M100.61M110.20M139.71M143.97M171.63M157.92M172.05M172.65M175.47M177.60M217.33M
Shares Outstanding (Diluted Average) (Quarter) 110.20M139.71M143.97M171.63M157.92M172.05M172.35M175.47M177.60M217.33M
EBITDA (Quarter) -13.12M-14.00M-12.47M-11.85M-17.72M-23.82M-23.78M-23.67M-26.65M-26.43M-30.65M-38.40M-46.93M-62.11M-65.25M33.23M-79.22M
Shares Outstanding (Quarter) 10.89M10.45M10.53M10.53M114.73M107.39M107.72M139.22M139.85M171.59M171.76M171.86M172.61M172.70M182.03M212.51M213.21M
Tax Rate (Quarter) -0.46-0.46-0.593.59-0.14-0.51-1.73-0.59-0.11-0.20-0.27-0.50-0.21-0.23-0.160.10-0.25